image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.705
6.61 %
$ 16.4 M
Market Cap
-0.29
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Jan, 31, 2025.

The intrinsic value of one COSM stock under the worst case scenario is HIDDEN Compared to the current market price of 0.705 USD, Cosmos Health Inc. is HIDDEN

This DCF valuation model was last updated on Jan, 31, 2025.

The intrinsic value of one COSM stock under the base case scenario is HIDDEN Compared to the current market price of 0.705 USD, Cosmos Health Inc. is HIDDEN

This DCF valuation model was last updated on Jan, 31, 2025.

The intrinsic value of one COSM stock under the best case scenario is HIDDEN Compared to the current market price of 0.705 USD, Cosmos Health Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS
FINANCIALS
53.4 M REVENUE
6.02%
-21.8 M OPERATING INCOME
-192.09%
-18.5 M NET INCOME
-34.07%
-15.6 M OPERATING CASH FLOW
-5.15%
-13.8 M INVESTING CASH FLOW
-63910.59%
12.7 M FINANCING CASH FLOW
-63.78%
12.4 M REVENUE
-6.02%
-2.24 M OPERATING INCOME
10.48%
-2.18 M NET INCOME
15.76%
740 K OPERATING CASH FLOW
161.09%
-35.4 K INVESTING CASH FLOW
-30.56%
2.68 M FINANCING CASH FLOW
396.60%
Balance Sheet Cosmos Health Inc.
image
Current Assets 36.6 M
Cash & Short-Term Investments 3.85 M
Receivables 19.8 M
Other Current Assets 13 M
Non-Current Assets 29.4 M
Long-Term Investments 166 K
PP&E 11.6 M
Other Non-Current Assets 17.6 M
Current Liabilities 24.3 M
Accounts Payable 11.9 M
Short-Term Debt 8.54 M
Other Current Liabilities 3.87 M
Non-Current Liabilities 5.65 M
Long-Term Debt 3.89 M
Other Non-Current Liabilities 1.76 M
EFFICIENCY
Earnings Waterfall Cosmos Health Inc.
image
Revenue 53.4 M
Cost Of Revenue 49 M
Gross Profit 4.35 M
Operating Expenses 26.2 M
Operating Income -21.8 M
Other Expenses -3.29 M
Net Income -18.5 M
RATIOS
8.15% GROSS MARGIN
8.15%
-40.90% OPERATING MARGIN
-40.90%
-34.74% NET MARGIN
-34.74%
-51.45% ROE
-51.45%
-28.09% ROA
-28.09%
-43.46% ROIC
-43.46%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Cosmos Health Inc.
image
Net Income -18.5 M
Depreciation & Amortization 614 K
Capital Expenditures -9.17 M
Stock-Based Compensation 578 K
Change in Working Capital -7.9 M
Others 5.84 M
Free Cash Flow -24.8 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Cosmos Health Inc.
image
COSM has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
6. Ownership
Insider Ownership Cosmos Health Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
475 K USD 2
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
49.8 K USD 1
9-12 MONTHS
Date Value Insider Amount Avg Price
2 weeks ago
Jan 17, 2025
Bought 25 K USD
Siokas Grigorios
Chief Executive Officer
+ 29158
0.8574 USD
2 weeks ago
Jan 16, 2025
Bought 40 K USD
Siokas Grigorios
Chief Executive Officer
+ 47904
0.835 USD
2 weeks ago
Jan 15, 2025
Bought 50 K USD
Siokas Grigorios
Chief Executive Officer
+ 62500
0.8 USD
2 weeks ago
Jan 14, 2025
Bought 60 K USD
Siokas Grigorios
Chief Executive Officer
+ 87247
0.6877 USD
2 weeks ago
Jan 13, 2025
Bought 100 K USD
Siokas Grigorios
Chief Executive Officer
+ 163666
0.611 USD
1 month ago
Dec 20, 2024
Bought 50 K USD
Terzis Georgios
Chief Financial Officer
+ 85778
0.5829 USD
1 month ago
Dec 20, 2024
Bought 150 K USD
Siokas Grigorios
Chief Executive Officer
+ 257334
0.5829 USD
11 months ago
Feb 16, 2024
Bought 49.8 K USD
Siokas Grigorios
Chief Executive Officer
+ 60000
0.8301 USD
1 year ago
Oct 12, 2023
Bought 159 K USD
Siokas Grigorios
Chief Executive Officer
+ 6712
23.66 USD
1 year ago
Jul 20, 2023
Bought 450 K USD
Siokas Grigorios
Chief Executive Officer
+ 181451
2.48 USD
1 year ago
Jun 06, 2023
Bought 107 K USD
Siokas Grigorios
Chief Executive Officer
+ 4474
23.92 USD
1 year ago
Apr 27, 2023
Bought 110 K USD
Siokas Grigorios
Chief Executive Officer
+ 4474
24.64 USD
1 year ago
Apr 21, 2023
Bought 110 K USD
Siokas Grigorios
Chief Executive Officer
+ 4474
24.49 USD
1 year ago
Apr 07, 2023
Bought 54.5 K USD
Siokas Grigorios
Chief Executive Officer
+ 2238
24.37 USD
2 years ago
Dec 19, 2022
Bought 3 M USD
Siokas Grigorios
director: Chief Executive Officer
+ 260870
11.5 USD
2 years ago
Dec 19, 2022
Bought 3 M USD
Siokas Grigorios
director: Chief Executive Officer
+ 260870
11.5 USD
2 years ago
Dec 19, 2022
Bought 3 M USD
Siokas Grigorios
director: Chief Executive Officer
+ 260870
11.5 USD
2 years ago
Nov 28, 2022
Bought 498 K USD
Siokas Grigorios
director: Chief Executive Officer
+ 801261
0.6215 USD
2 years ago
Nov 28, 2022
Bought 498 K USD
Siokas Grigorios
director: Chief Executive Officer
+ 801261
0.6215 USD
2 years ago
Nov 28, 2022
Sell 310 USD
Siokas Grigorios
director: Chief Executive Officer
- 498
0.6215 USD
2 years ago
Oct 20, 2022
Bought 1.5 M USD
Siokas Grigorios
director: Chief Executive Officer
+ 12500000
0.12 USD
2 years ago
Oct 20, 2022
Bought 1.5 M USD
Siokas Grigorios
director: Chief Executive Officer
+ 12500000
0.12 USD
2 years ago
Oct 20, 2022
Bought 637 K USD
Siokas Grigorios
director: Chief Executive Officer
+ 5309564
0.12 USD
2 years ago
Jun 15, 2022
Bought 311 K USD
Siokas Grigorios
Chief Executive Officer
+ 500000
0.6215 USD
2 years ago
Jun 15, 2022
Bought 932 USD
Siokas Grigorios
Chief Executive Officer
+ 1500
0.6215 USD
2 years ago
Jun 15, 2022
Bought 311 K USD
Siokas Grigorios
Chief Executive Officer
+ 500000
0.6215 USD
2 years ago
Jun 15, 2022
Bought 932 USD
Siokas Grigorios
director: Chief Executive Officer
+ 1500
0.6215 USD
3 years ago
Dec 08, 2021
Bought 750 K USD
Siokas Grigorios
Chief Executive Officer
+ 125000
6 USD
3 years ago
Oct 22, 2021
Sell 26.4 K USD
Siokas Grigorios
Chief Executive Officer
- 220000
0.12 USD
3 years ago
Oct 22, 2021
Sell 352 USD
Siokas Grigorios
Chief Executive Officer
- 2200
0.16 USD
3 years ago
Oct 22, 2021
Sell 5.7 K USD
Siokas Grigorios
Chief Executive Officer
- 30000
0.19 USD
3 years ago
Oct 22, 2021
Sell 1.17 K USD
Siokas Grigorios
Chief Executive Officer
- 4500
0.26 USD
3 years ago
Oct 22, 2021
Sell 2.36 K USD
Siokas Grigorios
Chief Executive Officer
- 8150
0.29 USD
3 years ago
Oct 22, 2021
Sell 1.16 K USD
Siokas Grigorios
Chief Executive Officer
- 2750
0.42 USD
3 years ago
Oct 22, 2021
Sell 11.6 K USD
Siokas Grigorios
Chief Executive Officer
- 15300
0.76 USD
3 years ago
Oct 22, 2021
Sell 117 K USD
Siokas Grigorios
Chief Executive Officer
- 30500
3.82 USD
3 years ago
Oct 22, 2021
Sell 116 K USD
Siokas Grigorios
Chief Executive Officer
- 28500
4.08 USD
3 years ago
Jul 20, 2021
Bought 100 USD
GOLDSTEIN PETER
director, 10 percent owner:
+ 100000
0.001 USD
3 years ago
Jul 20, 2021
Sell 100 USD
Siokas Grigorios
Chief Executive Officer
- 100000
0.001 USD
3 years ago
Jul 20, 2021
Sell 1.19 K USD
Siokas Grigorios
Chief Executive Officer
- 4250
0.28 USD
3 years ago
Jul 20, 2021
Sell 1.17 K USD
Siokas Grigorios
Chief Executive Officer
- 3000
0.39 USD
3 years ago
Jul 20, 2021
Sell 1.18 K USD
Siokas Grigorios
Chief Executive Officer
- 2500
0.47 USD
3 years ago
Jul 20, 2021
Sell 354 K USD
Siokas Grigorios
Chief Executive Officer
- 93300
3.79 USD
3 years ago
Jul 20, 2021
Sell 88.5 K USD
Siokas Grigorios
Chief Executive Officer
- 23300
3.8 USD
3 years ago
Jul 20, 2021
Sell 47.4 K USD
Siokas Grigorios
Chief Executive Officer
- 12300
3.85 USD
3 years ago
Jul 20, 2021
Sell 142 K USD
Siokas Grigorios
Chief Executive Officer
- 34800
4.07 USD
3 years ago
Jul 19, 2021
Bought 1.25 M USD
Siokas Grigorios
Chief Executive Officer
+ 208333
6 USD
3 years ago
Jul 13, 2021
Bought 1 M USD
Siokas Grigorios
Chief Executive Officer
+ 166667
6 USD
3 years ago
Jun 23, 2021
Bought 3 M USD
Siokas Grigorios
Chief Executive Officer
+ 500000
6 USD
3 years ago
Jun 17, 2021
Sell 122 K USD
Siokas Grigorios
Chief Executive Officer
- 392000
0.31 USD
3 years ago
Jun 17, 2021
Sell 18 K USD
Siokas Grigorios
Chief Executive Officer
- 50000
0.36 USD
3 years ago
Jun 17, 2021
Sell 12 K USD
Siokas Grigorios
Chief Executive Officer
- 20000
0.6 USD
3 years ago
Jun 17, 2021
Sell 85 K USD
Siokas Grigorios
Chief Executive Officer
- 100000
0.85 USD
3 years ago
Apr 27, 2021
Sell 50 USD
Siokas Grigorios
Chief Executive Officer
- 50000
0.001 USD
3 years ago
Apr 27, 2021
Sell 234 USD
Siokas Grigorios
Chief Executive Officer
- 23382
0.01 USD
3 years ago
Apr 27, 2021
Sell 1.5 K USD
Siokas Grigorios
Chief Executive Officer
- 150000
0.01 USD
3 years ago
Apr 27, 2021
Sell 500 USD
Siokas Grigorios
Chief Executive Officer
- 5000
0.1 USD
3 years ago
Apr 27, 2021
Sell 16 K USD
Siokas Grigorios
Chief Executive Officer
- 133500
0.12 USD
3 years ago
Apr 27, 2021
Sell 600 USD
Siokas Grigorios
Chief Executive Officer
- 2000
0.3 USD
3 years ago
Apr 27, 2021
Sell 2.4 K USD
Siokas Grigorios
Chief Executive Officer
- 6000
0.4 USD
3 years ago
Apr 27, 2021
Sell 3.02 K USD
Siokas Grigorios
Chief Executive Officer
- 7200
0.42 USD
3 years ago
Apr 27, 2021
Sell 6 K USD
Siokas Grigorios
Chief Executive Officer
- 12000
0.5 USD
3 years ago
Apr 27, 2021
Sell 6 K USD
Siokas Grigorios
Chief Executive Officer
- 10000
0.6 USD
3 years ago
Apr 27, 2021
Sell 6.07 K USD
Siokas Grigorios
Chief Executive Officer
- 9200
0.66 USD
3 years ago
Apr 27, 2021
Sell 507 K USD
Siokas Grigorios
Chief Executive Officer
- 143750
3.53 USD
3 years ago
Apr 27, 2021
Sell 50 K USD
Siokas Grigorios
Chief Executive Officer
- 13000
3.85 USD
3 years ago
Apr 27, 2021
Sell 107 K USD
Siokas Grigorios
Chief Executive Officer
- 26500
4.02 USD
3 years ago
Apr 27, 2021
Sell 24.2 K USD
Siokas Grigorios
Chief Executive Officer
- 6000
4.03 USD
4 years ago
Jan 20, 2021
Sell 150 USD
Siokas Grigorios
Chief Executive Officer
- 14990
0.01 USD
4 years ago
Jan 20, 2021
Sell 1.2 K USD
Siokas Grigorios
Chief Executive Officer
- 10000
0.12 USD
4 years ago
Jan 20, 2021
Sell 11.9 K USD
Siokas Grigorios
Chief Executive Officer
- 42500
0.28 USD
4 years ago
Jan 20, 2021
Sell 6 K USD
Siokas Grigorios
Chief Executive Officer
- 20000
0.3 USD
4 years ago
Jan 20, 2021
Sell 90.4 K USD
Siokas Grigorios
Chief Executive Officer
- 28000
3.23 USD
4 years ago
Dec 21, 2020
Sell 10 USD
Siokas Grigorios
Chief Executive Officer
- 10000
0.001 USD
4 years ago
Oct 19, 2020
Sell 28.4 USD
Siokas Grigorios
Chief Executive Officer
- 7100
0.004 USD
4 years ago
Oct 12, 2020
Sell 25 USD
Siokas Grigorios
Chief Executive Officer
- 25000
0.001 USD
4 years ago
Jul 29, 2020
Sell 25 USD
Siokas Grigorios
Chief Executive Officer
- 25000
0.001 USD
4 years ago
Jul 29, 2020
Sell 600 USD
Siokas Grigorios
Chief Executive Officer
- 30000
0.02 USD
4 years ago
Jul 29, 2020
Sell 120 USD
Siokas Grigorios
Chief Executive Officer
- 4000
0.03 USD
4 years ago
Jul 29, 2020
Sell 54 K USD
Siokas Grigorios
Chief Executive Officer
- 20000
2.7 USD
5 years ago
Sep 06, 2019
Sell 2.42 K USD
Siokas Grigorios
Chief Executive Officer
- 22000
0.11 USD
5 years ago
Sep 06, 2019
Sell 1.08 K USD
Siokas Grigorios
Chief Executive Officer
- 6000
0.18 USD
5 years ago
Sep 06, 2019
Sell 22 K USD
Siokas Grigorios
Chief Executive Officer
- 6666
3.3 USD
5 years ago
Jun 24, 2019
Bought 550 K USD
Siokas Grigorios
Chief Executive Officer
+ 73334
7.5 USD
5 years ago
Jun 18, 2019
Sell 220 USD
Siokas Grigorios
Chief Executive Officer
- 2200
0.1 USD
5 years ago
Jun 18, 2019
Sell 33.7 K USD
Siokas Grigorios
Chief Executive Officer
- 7800
4.32 USD
5 years ago
Jun 18, 2019
Sell 90 K USD
Siokas Grigorios
Chief Executive Officer
- 20000
4.5 USD
5 years ago
May 28, 2019
Bought 500 K USD
Siokas Grigorios
Chief Executive Officer
+ 66667
7.5 USD
5 years ago
May 28, 2019
Sell 500 K USD
Siokas Grigorios
Chief Executive Officer
- 200000
2.5 USD
5 years ago
Feb 27, 2019
Sell 1.14 K USD
Siokas Grigorios
Chief Executive Officer
- 10400
0.11 USD
5 years ago
Feb 27, 2019
Sell 113 K USD
Siokas Grigorios
Chief Executive Officer
- 27000
4.2 USD
6 years ago
Dec 20, 2018
Sell 5.67 K USD
Siokas Grigorios
Chief Executive Officer
- 16200
0.35 USD
6 years ago
Dec 20, 2018
Sell 57.2 K USD
Siokas Grigorios
Chief Executive Officer
- 130000
0.44 USD
6 years ago
Dec 20, 2018
Sell 2.28 K USD
Siokas Grigorios
Chief Executive Officer
- 4000
0.57 USD
6 years ago
Dec 20, 2018
Sell 1.14 K USD
Siokas Grigorios
Chief Executive Officer
- 1900
0.6 USD
6 years ago
Dec 20, 2018
Sell 5.68 K USD
Siokas Grigorios
Chief Executive Officer
- 8000
0.71 USD
6 years ago
Dec 20, 2018
Sell 1.14 K USD
Siokas Grigorios
Chief Executive Officer
- 1200
0.95 USD
6 years ago
Dec 20, 2018
Sell 5.67 K USD
Siokas Grigorios
Chief Executive Officer
- 3000
1.89 USD
6 years ago
Dec 20, 2018
Sell 1.7 M USD
Siokas Grigorios
Chief Executive Officer
- 380000
4.48 USD
6 years ago
Oct 30, 2018
Sell 4 K USD
Siokas Grigorios
Chief Executive Officer
- 40030
0.1 USD
6 years ago
Oct 30, 2018
Sell 4.46 K USD
Siokas Grigorios
Chief Executive Officer
- 40520
0.11 USD
6 years ago
Oct 30, 2018
Sell 580 USD
Siokas Grigorios
Chief Executive Officer
- 2000
0.29 USD
6 years ago
Oct 30, 2018
Sell 1.01 K USD
Siokas Grigorios
Chief Executive Officer
- 2400
0.42 USD
6 years ago
Oct 30, 2018
Sell 343 USD
Siokas Grigorios
Chief Executive Officer
- 700
0.49 USD
6 years ago
Oct 30, 2018
Sell 570 USD
Siokas Grigorios
Chief Executive Officer
- 1000
0.57 USD
6 years ago
Oct 30, 2018
Sell 21.9 K USD
Siokas Grigorios
Chief Executive Officer
- 30000
0.73 USD
6 years ago
Oct 30, 2018
Sell 285 K USD
Siokas Grigorios
Chief Executive Officer
- 71875
3.97 USD
6 years ago
Oct 30, 2018
Sell 7.98 K USD
Siokas Grigorios
Chief Executive Officer
- 2000
3.99 USD
6 years ago
Oct 30, 2018
Sell 5.7 K USD
Siokas Grigorios
Chief Executive Officer
- 1250
4.56 USD
6 years ago
Oct 25, 2018
Sell 285 K USD
Siokas Grigorios
Chief Executive Officer
- 71875
3.97 USD
6 years ago
Jul 09, 2018
Sell 5.88 K USD
Siokas Grigorios
Chief Executive Officer
- 58750
0.1 USD
6 years ago
Jul 09, 2018
Sell 440 USD
Siokas Grigorios
Chief Executive Officer
- 4000
0.11 USD
6 years ago
Jul 09, 2018
Sell 2.32 K USD
Siokas Grigorios
Chief Executive Officer
- 8000
0.29 USD
6 years ago
Jul 09, 2018
Sell 587 USD
Siokas Grigorios
Chief Executive Officer
- 827
0.71 USD
6 years ago
Jul 09, 2018
Sell 10.5 K USD
Siokas Grigorios
Chief Executive Officer
- 1840
5.72 USD
6 years ago
Jul 09, 2018
Sell 93.6 K USD
Siokas Grigorios
Chief Executive Officer
- 15500
6.04 USD
6 years ago
Jul 09, 2018
Sell 6 K USD
Siokas Grigorios
Chief Executive Officer
- 650
9.23 USD
6 years ago
Mar 30, 2018
Sell 12.9 K USD
Siokas Grigorios
Chief Executive Officer
- 129005
0.1 USD
6 years ago
Mar 30, 2018
Sell 1.02 K USD
Siokas Grigorios
Chief Executive Officer
- 5125
0.2 USD
6 years ago
Mar 30, 2018
Sell 6.2 K USD
Siokas Grigorios
Chief Executive Officer
- 10000
0.62 USD
6 years ago
Mar 30, 2018
Sell 4.96 K USD
Siokas Grigorios
Chief Executive Officer
- 4100
1.21 USD
6 years ago
Mar 30, 2018
Sell 12.4 K USD
Siokas Grigorios
Chief Executive Officer
- 2050
6.05 USD
6 years ago
Mar 30, 2018
Sell 248 K USD
Siokas Grigorios
Chief Executive Officer
- 35000
7.09 USD
6 years ago
Mar 30, 2018
Sell 35 K USD
Siokas Grigorios
Chief Executive Officer
- 4200
8.33 USD
6 years ago
Mar 30, 2018
Sell 620 K USD
Siokas Grigorios
Chief Executive Officer
- 70000
8.86 USD
6 years ago
Mar 28, 2018
Sell 970 USD
Siokas Grigorios
Chief Executive Officer
- 9700
0.1 USD
6 years ago
Mar 28, 2018
Sell 1.24 K USD
Siokas Grigorios
Chief Executive Officer
- 4000
0.31 USD
6 years ago
Mar 28, 2018
Sell 2.46 K USD
Siokas Grigorios
Chief Executive Officer
- 6000
0.41 USD
6 years ago
Mar 28, 2018
Sell 366 USD
Siokas Grigorios
Chief Executive Officer
- 600
0.61 USD
6 years ago
Mar 28, 2018
Sell 1.23 K USD
Siokas Grigorios
Chief Executive Officer
- 1600
0.77 USD
6 years ago
Mar 28, 2018
Sell 12.2 K USD
Siokas Grigorios
Chief Executive Officer
- 12000
1.02 USD
6 years ago
Mar 28, 2018
Sell 1.23 K USD
Siokas Grigorios
Chief Executive Officer
- 800
1.54 USD
6 years ago
Mar 28, 2018
Sell 11.9 K USD
Siokas Grigorios
Chief Executive Officer
- 1500
7.95 USD
6 years ago
Mar 28, 2018
Sell 88 K USD
Siokas Grigorios
Chief Executive Officer
- 10000
8.8 USD
6 years ago
Mar 28, 2018
Sell 12.3 K USD
Siokas Grigorios
Chief Executive Officer
- 1250
9.83 USD
6 years ago
Mar 28, 2018
Sell 3.07 K USD
Siokas Grigorios
Chief Executive Officer
- 300
10.24 USD
7 years ago
Dec 13, 2017
Sell 1.46 K USD
Siokas Grigorios
Chief Executive Officer
- 146000
0.01 USD
7 years ago
Dec 13, 2017
Sell 826 USD
Siokas Grigorios
Chief Executive Officer
- 7000
0.118 USD
7 years ago
Dec 13, 2017
Sell 2.36 K USD
Siokas Grigorios
Chief Executive Officer
- 4670
0.505 USD
7 years ago
Dec 13, 2017
Sell 5.19 K USD
Siokas Grigorios
Chief Executive Officer
- 5800
0.895 USD
7 years ago
Dec 13, 2017
Sell 35.4 K USD
Siokas Grigorios
Chief Executive Officer
- 38000
0.932 USD
7 years ago
Dec 13, 2017
Sell 23.6 K USD
Siokas Grigorios
Chief Executive Officer
- 20000
1.18 USD
7 years ago
Dec 13, 2017
Sell 11.8 K USD
Siokas Grigorios
Chief Executive Officer
- 1700
6.94 USD
7 years ago
Oct 23, 2017
Sell 58.8 K USD
Siokas Grigorios
Chief Executive Officer
- 120000
0.49 USD
7 years ago
Oct 23, 2017
Sell 29.4 K USD
Siokas Grigorios
Chief Executive Officer
- 50000
0.588 USD
7 years ago
Oct 16, 2017
Sell 1.99 K USD
Siokas Grigorios
Chief Executive Officer
- 198920
0.01 USD
7 years ago
Oct 16, 2017
Sell 585 USD
Siokas Grigorios
Chief Executive Officer
- 22500
0.026 USD
7 years ago
Oct 16, 2017
Sell 585 USD
Siokas Grigorios
Chief Executive Officer
- 15000
0.039 USD
7 years ago
Oct 16, 2017
Sell 7.05 K USD
Siokas Grigorios
Chief Executive Officer
- 150000
0.047 USD
7 years ago
Oct 16, 2017
Sell 1.76 K USD
Siokas Grigorios
Chief Executive Officer
- 21000
0.084 USD
7 years ago
Oct 16, 2017
Sell 11 K USD
Siokas Grigorios
Chief Executive Officer
- 110000
0.1 USD
7 years ago
Oct 16, 2017
Sell 12.4 K USD
Siokas Grigorios
Chief Executive Officer
- 40000
0.31 USD
7 years ago
Oct 16, 2017
Sell 29.5 K USD
Siokas Grigorios
Chief Executive Officer
- 50000
0.59 USD
7 years ago
Oct 16, 2017
Sell 23.4 K USD
Siokas Grigorios
Chief Executive Officer
- 30000
0.78 USD
7 years ago
May 31, 2017
Sell 5.62 K USD
Siokas Grigorios
Chief Executive Officer
- 562000
0.01 USD
7 years ago
May 31, 2017
Sell 960 USD
Siokas Grigorios
Chief Executive Officer
- 80000
0.012 USD
7 years ago
May 31, 2017
Sell 6.66 K USD
Siokas Grigorios
Chief Executive Officer
- 185000
0.036 USD
7 years ago
May 31, 2017
Sell 1.1 K USD
Siokas Grigorios
Chief Executive Officer
- 25000
0.044 USD
7 years ago
May 31, 2017
Sell 2.21 K USD
Siokas Grigorios
Chief Executive Officer
- 32000
0.069 USD
7 years ago
May 31, 2017
Sell 1.1 K USD
Siokas Grigorios
Chief Executive Officer
- 15000
0.073 USD
7 years ago
May 31, 2017
Sell 66 K USD
Siokas Grigorios
Chief Executive Officer
- 82500
0.8 USD
7 years ago
May 31, 2017
Sell 11 K USD
Siokas Grigorios
Chief Executive Officer
- 13000
0.846 USD
7 years ago
Apr 05, 2017
Sell 3.12 K USD
Siokas Grigorios
Chief Executive Officer
- 240000
0.013 USD
7 years ago
Apr 05, 2017
Sell 300 USD
Siokas Grigorios
Chief Executive Officer
- 20000
0.015 USD
7 years ago
Apr 05, 2017
Sell 2.02 K USD
Siokas Grigorios
Chief Executive Officer
- 101000
0.02 USD
7 years ago
Apr 05, 2017
Sell 500 USD
Siokas Grigorios
Chief Executive Officer
- 20000
0.025 USD
7 years ago
Apr 05, 2017
Sell 1.02 K USD
Siokas Grigorios
Chief Executive Officer
- 35000
0.029 USD
7 years ago
Apr 05, 2017
Sell 1.01 K USD
Siokas Grigorios
Chief Executive Officer
- 24000
0.042 USD
7 years ago
Apr 05, 2017
Sell 3.14 K USD
Siokas Grigorios
Chief Executive Officer
- 42500
0.074 USD
7 years ago
Apr 05, 2017
Sell 105 K USD
Siokas Grigorios
Chief Executive Officer
- 1000000
0.105 USD
7 years ago
Apr 05, 2017
Sell 27.6 K USD
Siokas Grigorios
Chief Executive Officer
- 45000
0.613 USD
7 years ago
Apr 05, 2017
Sell 8 K USD
Siokas Grigorios
Chief Executive Officer
- 12000
0.667 USD
7 years ago
Apr 05, 2017
Sell 10.6 K USD
Siokas Grigorios
Chief Executive Officer
- 14300
0.74 USD
7 years ago
Apr 05, 2017
Sell 21.3 K USD
Siokas Grigorios
Chief Executive Officer
- 24000
0.888 USD
7 years ago
Mar 01, 2017
Sell 38.5 K USD
Siokas Grigorios
Chief Executive Officer
- 55000
0.7 USD
7 years ago
Mar 01, 2017
Sell 12.5 K USD
Siokas Grigorios
Chief Executive Officer
- 36000
0.346 USD
7 years ago
Mar 01, 2017
Sell 10 K USD
Siokas Grigorios
Chief Executive Officer
- 33333
0.3 USD
7 years ago
Mar 01, 2017
Sell 51.4 K USD
Siokas Grigorios
Chief Executive Officer
- 650000
0.079 USD
7 years ago
Mar 01, 2017
Sell 2.95 K USD
Siokas Grigorios
Chief Executive Officer
- 295400
0.01 USD
7 years ago
Mar 02, 2017
Sell 8.91 K USD
Siokas Grigorios
Chief Executive Officer
- 297000
0.03 USD
7 years ago
Feb 06, 2017
Sell 9.66 K USD
Siokas Grigorios
Chief Executive Officer
- 140000
0.069 USD
7 years ago
Feb 08, 2017
Sell 5.4 K USD
Siokas Grigorios
Chief Executive Officer
- 135000
0.04 USD
8 years ago
Jan 17, 2017
Sell 21 K USD
Siokas Grigorios
Chief Executive Officer
- 700000
0.03 USD
8 years ago
Jan 17, 2017
Sell 250 USD
Siokas Grigorios
Chief Executive Officer
- 250000
0.001 USD
8 years ago
Jan 17, 2017
Sell 5.31 K USD
Siokas Grigorios
Chief Executive Officer
- 177000
0.03 USD
8 years ago
Nov 04, 2016
Sell 114 USD
Siokas Grigorios
Chief Executive Officer
- 114000
0.001 USD
8 years ago
Nov 04, 2016
Sell 600 USD
Siokas Grigorios
Chief Executive Officer
- 60000
0.01 USD
8 years ago
Oct 07, 2016
Sell 80 USD
Siokas Grigorios
Chief Executive Officer
- 80000
0.001 USD
8 years ago
Sep 30, 2016
Sell 1.5 K USD
Siokas Grigorios
Chief Executive Officer
- 75000
0.02 USD
8 years ago
Sep 15, 2016
Sell 157 USD
Siokas Grigorios
Chief Executive Officer
- 157000
0.001 USD
8 years ago
Sep 15, 2016
Sell 23 K USD
Siokas Grigorios
Chief Executive Officer
- 150000
0.153 USD
8 years ago
Sep 16, 2016
Sell 6.68 K USD
Siokas Grigorios
Chief Executive Officer
- 75000
0.089 USD
8 years ago
Sep 16, 2016
Sell 1.23 K USD
Siokas Grigorios
Chief Executive Officer
- 410000
0.003 USD
8 years ago
Sep 16, 2016
Sell 1.95 K USD
Siokas Grigorios
Chief Executive Officer
- 1953500
0.001 USD
8 years ago
Aug 11, 2016
Sell 55 K USD
Siokas Grigorios
CEO, CFO
- 137500
0.4 USD
9 years ago
Jan 11, 2016
Bought 0 USD
Siokas Grigorios
10 percent owner
+ 2000000
0 USD
9 years ago
Jan 08, 2016
Bought 0 USD
Siokas Grigorios
10 percent owner
+ 2400000
0 USD
9 years ago
Jan 08, 2016
Bought 0 USD
Siokas Grigorios
10 percent owner
+ 4316666
0 USD
9 years ago
Nov 04, 2015
Sell 95 M USD
Goulielmos Dimitrios
Chief Executive Officer
- 95000000
1 USD
11 years ago
May 29, 2013
Bought 10.1 K USD
MAVROGIANNIS VASILEIOS
10 percent owner
+ 675000
0.015 USD
11 years ago
May 29, 2013
Sell 10.7 K USD
MAVROGIANNIS VASILEIOS
10 percent owner
- 266667
0.04 USD
11 years ago
May 29, 2013
Sell 10.7 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 266667
0.04 USD
11 years ago
May 15, 2013
Sell 2 K USD
MAVROGIANNIS VASILEIOS
10 percent owner
- 50000
0.04 USD
11 years ago
Apr 09, 2013
Bought 5 K USD
MAVROGIANNIS VASILEIOS
10 percent owner
+ 50000
0.1 USD
11 years ago
Feb 22, 2013
Sell 6 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 100000
0.06 USD
11 years ago
Feb 22, 2013
Sell 2 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 50000
0.04 USD
11 years ago
Feb 22, 2013
Sell 13.2 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 330000
0.04 USD
11 years ago
Feb 22, 2013
Sell 4 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 100000
0.04 USD
11 years ago
Feb 22, 2013
Sell 6 K USD
MAVROGIANNIS VASILEIOS
10 percent owner
- 100000
0.06 USD
11 years ago
Feb 22, 2013
Sell 2 K USD
MAVROGIANNIS VASILEIOS
10 percent owner
- 50000
0.04 USD
11 years ago
Feb 22, 2013
Sell 13.2 K USD
MAVROGIANNIS VASILEIOS
10 percent owner
- 330000
0.04 USD
11 years ago
Feb 22, 2013
Sell 4 K USD
MAVROGIANNIS VASILEIOS
10 percent owner
- 100000
0.04 USD
12 years ago
Jan 08, 2013
Sell 4 K USD
MAVROGIANNIS VASILEIOS
10 percent owner
- 100000
0.04 USD
12 years ago
Jan 09, 2013
Sell 5.2 K USD
MAVROGIANNIS VASILEIOS
10 percent owner
- 130000
0.04 USD
12 years ago
Jan 09, 2013
Sell 1.4 K USD
MAVROGIANNIS VASILEIOS
10 percent owner
- 35000
0.04 USD
12 years ago
Jan 09, 2013
Sell 7 K USD
MAVROGIANNIS VASILEIOS
10 percent owner
- 100000
0.07 USD
12 years ago
Jan 08, 2013
Sell 4 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 100000
0.04 USD
12 years ago
Jan 09, 2013
Sell 5.2 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 130000
0.04 USD
12 years ago
Jan 09, 2013
Sell 1.4 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 35000
0.04 USD
12 years ago
Jan 09, 2013
Sell 7 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 100000
0.07 USD
12 years ago
Dec 07, 2012
Sell 480 USD
MAVROGIANNIS VASILEIOS
CFO
- 12000
0.04 USD
12 years ago
Dec 07, 2012
Sell 5.04 K USD
MAVROGIANNIS VASILEIOS
CFO
- 126000
0.04 USD
12 years ago
Dec 07, 2012
Sell 4.4 K USD
MAVROGIANNIS VASILEIOS
CFO
- 110000
0.04 USD
12 years ago
Dec 07, 2012
Sell 600 USD
MAVROGIANNIS VASILEIOS
CFO
- 15000
0.04 USD
12 years ago
Dec 07, 2012
Sell 4.4 K USD
MAVROGIANNIS VASILEIOS
CFO
- 110000
0.04 USD
12 years ago
Dec 07, 2012
Sell 600 USD
MAVROGIANNIS VASILEIOS
CFO
- 15000
0.04 USD
12 years ago
Dec 07, 2012
Sell 1.6 K USD
MAVROGIANNIS VASILEIOS
CFO
- 40000
0.04 USD
12 years ago
Dec 07, 2012
Sell 480 USD
DRAKOPOULOS PANAGIOTIS
CEO
- 12000
0.04 USD
12 years ago
Dec 07, 2012
Sell 5.04 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 126000
0.04 USD
12 years ago
Dec 07, 2012
Sell 4.4 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 110000
0.04 USD
12 years ago
Dec 07, 2012
Sell 600 USD
DRAKOPOULOS PANAGIOTIS
CEO
- 15000
0.04 USD
12 years ago
Dec 07, 2012
Sell 4.4 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 110000
0.04 USD
12 years ago
Dec 07, 2012
Sell 600 USD
DRAKOPOULOS PANAGIOTIS
CEO
- 15000
0.04 USD
12 years ago
Dec 07, 2012
Sell 1.6 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 40000
0.04 USD
12 years ago
Oct 25, 2012
Sell 4 K USD
MAVROGIANNIS VASILEIOS
CFO
- 100000
0.04 USD
12 years ago
Oct 25, 2012
Sell 4 K USD
MAVROGIANNIS VASILEIOS
CFO
- 100000
0.04 USD
12 years ago
Oct 25, 2012
Sell 6 K USD
MAVROGIANNIS VASILEIOS
CFO
- 150000
0.04 USD
12 years ago
Oct 25, 2012
Sell 4 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 100000
0.04 USD
12 years ago
Oct 25, 2012
Sell 4 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 100000
0.04 USD
12 years ago
Oct 25, 2012
Sell 6 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 150000
0.04 USD
12 years ago
Oct 01, 2012
Sell 12.8 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 40000
0.32 USD
12 years ago
Oct 01, 2012
Sell 25.8 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 64500
0.4 USD
12 years ago
Oct 01, 2012
Sell 2.4 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 60000
0.04 USD
12 years ago
Oct 01, 2012
Sell 9.86 K USD
DRAKOPOULOS PANAGIOTIS
CEO
- 29000
0.34 USD
12 years ago
Oct 01, 2012
Sell 12.8 K USD
MAVROGIANNIS VASILEIOS
CFO
- 40000
0.32 USD
12 years ago
Oct 01, 2012
Sell 25.8 K USD
MAVROGIANNIS VASILEIOS
CFO
- 64500
0.4 USD
12 years ago
Oct 01, 2012
Sell 2.4 K USD
MAVROGIANNIS VASILEIOS
CFO
- 60000
0.04 USD
12 years ago
Oct 01, 2012
Sell 9.86 K USD
MAVROGIANNIS VASILEIOS
CFO
- 29000
0.34 USD
7. News
Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million CHICAGO, IL / ACCESS Newswire / January 22, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has secured buy-out rights and exclusive licensing for two patented anticancer drugs targeting, among others, prostate, ovarian, and colorectal cancers. Both of these innovative anticancer therapies, developed through cutting-edge oncology research, are protected by international patents and set to commence Clinical Phase I trials. accessnewswire.com - 1 week ago
Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days CHICAGO, IL / ACCESS Newswire / January 21, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that its CEO, Greg Siokas, has increased his stake in the Company by acquiring a total of 647,809 common shares, valued at $425,000, across six transactions between December 20, 2024, and January 17, 2025. As a result of these transactions, Mr. accessnewswire.com - 1 week ago
Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries CHICAGO, IL / ACCESSWIRE / January 13, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has entered into a distribution agreement with Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax") to distribute Virax-branded Avian Influenza Virus ("AIV") Real-Time PCR Kits across various major European markets and certain Gulf Cooperation Council (GCC) countries. Specifically, Cosmos Health gains exclusive rights to distribute these kits in Greece and Cyprus, as well as non-exclusive rights in select European countries, including France, Portugal, Spain, The Netherlands, Belgium, Sweden, Finland, Denmark, Norway, Germany, Switzerland, and Austria. accesswire.com - 2 weeks ago
Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology CHICAGO, IL / ACCESSWIRE / December 26, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology at the Company's Research and Development division. Professor Trafalis currently serves as a Professor of Pharmacology and Clinical Pharmacology at the Faculty of Medicine, National and Kapodistrian University of Athens. accesswire.com - 1 month ago
Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000 CHICAGO, IL / ACCESSWIRE / December 23, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that its CEO, Greg Siokas, and CFO, George Terzis, increased their stake in the Company by approximately 343,122 common shares, valued at $200,000, based on the closing share price on Friday, December 20, 2024. Specifically, Mr. accesswire.com - 1 month ago
Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets CHICAGO, IL / ACCESSWIRE / November 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has adopted a strategy to include Bitcoin and Ethereum as part of its treasury reserve assets. The adoption of this new policy follows the Company's forward-thinking approach to investing in new technologies, including the recent acquisition of Cloudscreen, its AI-driven drug repurposing platform. accesswire.com - 2 months ago
Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M Stable revenue and gross profit despite cost-cutting initiatives, indicating the strength of underlying segments and brands. Solid liquidity position, with cash and cash equivalents exceeding $3.3 million. accesswire.com - 2 months ago
Cosmos Health Issues Letter to Shareholders CHICAGO, IL / ACCESSWIRE / November 12, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that its Chief Executive Officer, Greg Siokas, has issued the following letter to the Company's shareholders. Dear Cosmos Health Shareholders, It has been just over a year since my previous shareholder letter, and I would like to express my sincere gratitude for your continued support. accesswire.com - 2 months ago
Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21% CHICAGO, IL / ACCESSWIRE / November 1, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that its healthcare distribution business, operated through its wholly owned subsidiary, CosmoFarm S.A. ("CosmoFarm"), has achieved record sales. accesswire.com - 3 months ago
Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands CHICAGO, IL / ACCESSWIRE / September 25, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that sales of its proprietary brands, including Sky Premium Life, on Amazon in the United Kingdom have surged by 160%, increasing to $596,000 year-to-date in 2024 from $230,000 during the same period in 2023. Greg Siokas, CEO of Cosmos Health, stated: "We are delighted that our proprietary brands are being very well received by UK consumers, achieving impressive growth. accesswire.com - 4 months ago
Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins CHICAGO, IL / ACCESSWIRE / September 23, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has received its first round of purchase orders in the United Kingdom (UK) for its antimicrobial wash, C-Scrub Wash Chlorhexidine 4% ('C-Scrub'), exceeding $500,000. The orders cover the period from July 2024 to September 2024. accesswire.com - 4 months ago
Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits CHICAGO, IL / ACCESSWIRE / September 23, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has entered into an exclusivity agreement with Virax Biolabs to distribute mpox (formerly monkeypox) virus real-time PCR detection kits across India. With a population of over 1.4 billion, India is an important region where enhanced detection capabilities are needed. accesswire.com - 4 months ago
8. Profile Summary

Cosmos Health Inc. COSM

image
COUNTRY US
INDUSTRY Drug Manufacturers - Specialty & Generic
MARKET CAP $ 16.4 M
Dividend Yield 0.00%
Description Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Contact 141 West Jackson Boulevard, Chicago, IL, 60604 https://www.cosmosholdingsinc.com
IPO Date July 23, 2010
Employees 123
Officers Mr. Nikolaos Bardakis Chief Operating Officer Mr. Georgios Terzis Chief Financial Officer Mr. Demetrios G. Demetriades Secretary & Independent Director Mr. Grigorios Siokas Chairman & Chief Executive Officer